MEL4B3, a novel mRNA is induced in skin tumors and regulated by TGF-β and pro-inflammatory cytokines

Experimental Dermatology

Volumn 14, Issue 9, 2005, Pages 709-718

  Anderegg, Ulf ^a   Breitschwerdt, Kerstin ^a   Köhler, Martin J ^a   Sticherling, Michael ^a   Haustein, Uwe Frithjof ^a   Simon, Jan C ^a   Saalbach, Anja ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Differential gene expression; Skin tumors; Stroma interaction; Tumor

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; INTERLEUKIN 1; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BASAL CELL CARCINOMA; CELL ACTIVATION; CELL LINE; CONTROLLED STUDY; DNA DETERMINATION; DNA ISOLATION; DNA SEQUENCE; EPIDERMIS; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; IN VITRO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; MELANOMA; MELANOMA CELL; METASTASIS; NUCLEOTIDE SEQUENCE; PSORIASIS; SEQUENCE HOMOLOGY; SKIN FIBROBLAST; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; SUPERNATANT; TUMOR GROWTH;

AMINO ACID SEQUENCE; BASE SEQUENCE; BLOTTING, NORTHERN; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; CULTURE MEDIA; CULTURE MEDIA, CONDITIONED; CYTOKINES; DNA, COMPLEMENTARY; FIBROBLASTS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; INFLAMMATION; KERATINOCYTES; MICROCIRCULATION; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, COMPLEMENTARY; RNA, MESSENGER; SKIN; SKIN NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 23844475503     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2005.00349.x     Document Type: Article

References (35)

1. Mei Yu, Hsu M Y, Meier F, Herlyn M. Melanoma development and progression: a conspiracy between tumor and host. Differentiation 2002: 70: 522-536.
2. Zigrino P, Löffek S, Mauch C. Tumor-stroma interactions: their role in the control of tumor cell invasion. Biochimie 2005: 87: 321-328.
3. Wandel E, Graßhoff A, Mittag M, Haustein U F, Saalbach A. Fibroblasts surrounding melanoma express elevated levels of matrix metalloproteinase-1 (MMP-1) and intercellular adhesion molecule-1 (ICAM-1) in vitro. Exp Dermatol 2000: 9: 34-41.
4. Wandel E, Raschke A, Hildebrandt G et al. Fibroblasts enhance the invasive capacity of melanoma cells in vitro. Arch Dermatol Res 2002: 293: 601-608.
5. Dummer R, Yue F Y, Pavlovic J et al. Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10. Br J Cancer 1998: 7: 1413-1419.
6. Shipley G D, Pittelkow M R. Control of growth and differentiation in vitro of human keratinocytes cultured in serum-free medium. Arch Dermatol 1987: 123: 1541a-1544a.
7. Saalbach A, Hildebrandt G, Haustein U F, Anderegg U. The Thy-1/Thy-1 ligand interaction is involved in binding of melanoma cells to activated Thy-1 positive microvascular endothelial cells. Microvascular Res 2002: 64: 86-93.
8. Saalbach A, Anderegg U, Schnabel E, Herrmann K, Haustein U F. A novel fibroblast specific antibody. Properties and specificties. J Invest Dermatol 1996: 106: 1314-1319.
9. Geertsen R C, Hofbauer G F L, Yue F Y, Manolio S, Burg G, Dummer R. Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions. J Invest Dermatol 1998: 111: 497-450.
10. Komminoth P. Detection of mRNA in tissue sections using DIG labeled RNA and oligonucleotide probes. In: Non Radioactive in Situ Hybridization Application Manual, 2nd edn. Mannheim: Boehringer, 1996, 126-135.
11. Anderegg U, Saalbach A, Haustein U F. Chemokine release from activated human dermal microvascular endothelial cells-implications for the pathophysiology of scleroderma? Arch Derm Res 2000: 292: 341-347.
12. Kunz-Schughart L, Knuechel R. Tumor-associated fibroblasts (PartI): Tumor-associated fibroblasts (part I). Active stromal participants in tumor development and progression? Histol Histopathol 2002: 17: 599-621.
13. Kunz-Schughart L, Knuechel R. Tumor-associated fibroblasts (PartII): functional impact on tumor tissue. Histol Histopathol 2002: 17: 623-637.
14. Löffek S, Zigrino P, Angel P, Anwald B, Krieg T, Mauch C. High invasive melanoma cells induce matrix metalloproteinase-1 synthesis in fibroblasts by interleukin-1alpha and basic fibroblast growth factor-mediated mechanisms. J Invest Dermatol 2005: 124: 638-643.
15. Berchem G, Glondu M, Gleizes M et al. Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 2002: 29: 5951-5955.
16. Airola K, Fusenig N E. Differential stromal regulation of MMP-1 expression in benign and malignant keratinocytes. J Invest Dermatol 2001: 116: 85-92.
17. Lazar-Molnar E, Hegyesi H, Toth Falus A. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 2000: 12: 547-554.
18. Morinaga Y, Fujita N, Ohishi K, Tsuruo T. Stimulation of interleukin-11 production from osteoblast-like cells by transforming growth factor-beta and tumor cell factors. Int J Cancer 1997: 71: 422-428.
19. Mori O, Hachisuka H, Sasai Y. Effects of transforming growth factor beta 1 in the hair cycle. J Dermatol 1996: 23: 89-94.
20. Soma T, Tsuji Y, Hibino T. Involvement of transforming growth factor-β2 in catagen induction during the human hair cycle. J Invest Dermatol 2002: 118: 993-997.
21. Rosenthal E, McCrory A, Talbert M, Young G, Murphy-Ullrich J, Gladson C. Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts. Mol Carcinog 2004: 40: 116-121.
22. Kircheis R, Ostermann E, Wolschek M F et al. Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity. Cancer Gene Ther 2002: 9: 673-680.
23. Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V. Serum values of tumor necrosis factor alpha and of soluble tumor necrosis factor R55 in melanoma patients. Melanoma Res 2000: 10: 253-258.
24. Salles G, Bienvenu G, Bastion Y et al. Elevated circulating levels of TNF alpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients. Br J Haematol 1996: 93: 352-359.
25. Yoshinaga Y, Higaki M, Terajima S et al. Detection of inflammatory cytokines in psoriatic skin. Arch Dermatol Res 1995: 287: 158-164.
26. La E, Rundhaug J E, Fischer S M. Role of intracellular interleukin-1 receptor antagonist in skin carcinogenesis. Mol Carcinog 2001: 30: 218-223.
27. Kamei T, Inui M, Nakamura S, Okumura K, Goto A, Tagawa T. Interferon-gamma and anti-Fas antibody-induced apoptosis in human melanoma cell lines and its relationship to bcl-2 cleavage and bak expression. Melanoma Res 2003: 13: 153-159.
28. Rodrigues E G, Travassos L R. Endogenous accumulation of IFN-gamma in IFN-gamma-R (-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo. Cytokines Cell Mol Ther 2003: 7: 107-116.
29. Giacomini P, Fisher P B, Duigou G J, Gambari R, Natali P G. Regulation of class II MHC gene expression by interferons: insights into mechanism action interferon. Anticancer Res 1988: 8: 1153-1161.
30. Carey T E, Takahashi T, Resnick L A, Oettgen H F, Old L J. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Nat Acad Sci USA 1976: 73: 3278-3282.
31. Bean M A, Bloom B R, Heberman R B et al. Cell-mediated cytotxicity for bladder carcinoma: evaluation of a workshop. Cancer Res 1975: 35: 2902-2913.
32. Aubert C, Rouge F, Reillaudou M, Metge P. Establishment and characterization of human ocular melanoma cell lines. Int J Cancer 1993: 54: 784-792.
33. Lockshin A, Giovanella B C, Vardeman D M et al. Effectiveness of anticancer drugs determined in nude mice inoculated with [125I]5-iodo-2′-deoxyuridine-prelabeled human melanoma cells. J Natl Cancer Inst 1985: 74: 899-903.
34. van Muijen G N P, Danen E H, Veerkamp E H, Ruiter D J, Lesley J, van den Heuvel L P. Glycokonjugate profile and CD44 expression in human melanoma cell lines with different metastatic capacity. Int J Cancer 1995: 61: 241-248.
35. Danen E H J, van Muijen G N P, Wiel van de Kemenade E, Jansen K F J, Ruiter D J, Figdor C G. Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and in non-metastatic and highly metastatic human melanoma cells. Int J Cancer 1993: 54: 315-321.